Australia's former national deputy chief medical officer says the country's doctors and medical experts "got it wrong" advising use of a COVID-19 medication thought to strongly reduce the risk of the illness becoming life-threatening.

Molnupiravir, sold in Australia under the brand name Lagevrio and bought in bulk by the federal government, disrupts COVID's ability to copy itself and was the first coronavirus antiviral to win government subsidy here.

Infectious diseases physician Dr Nick Coatsworth told Liam Bartlett on 6PR Mornings preliminary findings from a major new study suggest the medication works no better than a placebo.

Australia's former national deputy chief medical officer says the country's doctors and medical experts "got it wrong" advising use of a COVID-19 medication thought to strongly reduce the risk of the illness becoming life-threatening.
Molnupiravir, sold in Australia under the brand name Lagevrio and bought in bulk by the federal government, disrupts COVID's ability to copy itself and was the first coronavirus antiviral to win government subsidy here.
Infectious diseases physician Dr Nick Coatsworth told Liam Bartlett on 6PR Mornings preliminary findings from a major new study suggest the medication works no better than a placebo.

Perth Today will keep you up to date with all the latest breaking stories and issues in Perth.

Perth Today will keep you up to date with all the latest breaking stories and issues in Perth.

Advertisement